Clinical observation in 31 cases of chronic bronchitis at remission stage treated with bufei keli.

Abstract

To observe the therapeutic effects of a Chinese drug Bufei Keli ([symbol: see text] granules for invigorating the lung) in the treatment of chronic bronchitis at remission stage, 62 cases were randomly divided into a treatment group (treated with Bufei Keli) and a control group (treated with Yupingfeng Keli [symbol: see text]). The results turned out to be that the short-term clinically controlled and markedly effective rate was 77.42% and the long-term relapse-resisting markedly effective rate was 74.2% in the treatment group, which were obviously higher than 45.16% and 38.71% respectively in the control group (P < 0.05). And the increase in contents of SOD and CD3 and the decrease in LPO content in the treatment group were also bigger than that in the control group (P < 0.01). It is therefore concluded that Bufei Keli can improve qi deficiency syndrome and raise the immunity of patients with chronic bronchitis, hence its effect of resisting relapse of chronic bronchitis.

• Authors: Yangchun Liu, Naihong Wang, Na Wang, Guanping Liu, Huifang Yan
• Journal: Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan (J Tradit Chin Med) Vol. 23 Issue 4 Pg. 246-50 (Dec 2003) ISSN: 0255-2922 [Print] China
• PMID: 14719287 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)

Chemical References

• Adjuvants, Immunologic
• CD3 Complex
• Drugs, Chinese Herbal

Topics

• Adjuvants, Immunologic (therapeutic use)
• Adult
• Aged
• Bronchitis, Chronic (drug therapy, immunology)
• CD3 Complex (blood)
• Convalescence
• Drugs, Chinese Herbal (therapeutic use)
• Female
• Humans
• Male
• Middle Aged
• Phytotherapy
• Qi
• Yang Deficiency (drug therapy, immunology)